Scarica l'app Stockscreener
11.83
1.33%
-0.16
Dopo l'orario di chiusura:
11.65
-0.18
-1.52%
Amylyx Pharmaceuticals Inc Azioni (AMLX) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
-
|
- | -0.665 | 0.416 | -1.023 |
| Cost Of Revenue |
-
|
- | - | - | 0.008 |
Selling, General, and Administrative
|
0.28%
15.64
|
15.68 | - | - | - |
| Costs And Expenses |
13.37%
42.86
|
37.80 | 39.99 | 76.08 | 75.26 |
| Operating Income/Loss |
13.37%
-42.86
|
-37.80 | -40.65 | -75.66 | -76.29 |
| Nonoperating Income/Loss |
25.42%
1.414
|
1.896 | 2.473 | 2.957 | 3.586 |
| Income/Loss From Continuing Operations Before Tax |
15.42%
-41.44
|
-35.91 | -38.18 | -72.70 | -72.70 |
| Income Tax Expense/Benefit |
-
|
- | -0.635 | - | - |
| Income/Loss From Continuing Operations After Tax |
15.42%
-41.44
|
-35.91 | -37.55 | -72.70 | -72.70 |
|
Net Income/Loss
|
15.42%
-41.44
|
-35.91 | -37.55 | -72.70 | -72.70 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
4.02%
89.14
|
85.70 | 0.1515 | 68.09 | 68.02 |
| Diluted Average Shares |
4.02%
89.14
|
85.70 | 0.1515 | 68.09 | 68.02 |
| Basic Earnings Per Share |
9.52%
-0.46
|
-0.42 | -0.54 | -1.07 | -1.07 |
| Diluted Earnings Per Share |
9.52%
-0.46
|
-0.42 | -0.54 | -1.07 | -1.07 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
2.41%
1.75%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):